Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.

Nemet, Ital; Kliker, Limor; Lustig, Yaniv; Zuckerman, Neta; Erster, Oran; Cohen, Carmit; Kreiss, Yitshak; Alroy-Preis, Sharon; Regev-Yochay, Gili; Mendelson, Ella; Mandelboim, Michal

Nemet, Ital; Kliker, Limor; Lustig, Yaniv; Zuckerman, Neta; Erster, Oran; Cohen, Carmit; Kreiss, Yitshak; Alroy-Preis, Sharon; Regev-Yochay, Gili; Mendelson, Ella; Mandelboim, Michal.

Nemet I; Ministry of Health, Ramat Gan, Israel.
Kliker L; Ministry of Health, Ramat Gan, Israel.
Lustig Y; Ministry of Health, Ramat Gan, Israel.
Zuckerman N; Ministry of Health, Ramat Gan, Israel.
Erster O; Ministry of Health, Ramat Gan, Israel.
Cohen C; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
Kreiss Y; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
Alroy-Preis S; Ministry of Health, Jerusalem, Israel.
Regev-Yochay G; Sheba Medical Center Tel Hashomer, Ramat Gan, Israel.
Mendelson E; Ministry of Health, Ramat Gan, Israel michal.mandelboim@sheba.health.gov.il.
Mandelboim M; Ministry of Health, Ramat Gan, Israel michal.mandelboim@sheba.health.gov.il.

N Engl J Med ; 386(5): 492-494, 2022 02 03.

Article in English | MEDLINE | ID: covidwho-1596397

Subject(s)

Antibodies, Neutralizing/blood; BNT162 Vaccine/administration & dosage; COVID-19 Vaccines/immunology; COVID-19/prevention & control; SARS-CoV-2/immunology; Vaccine Efficacy; BNT162 Vaccine/immunology; Humans; Immunization, Secondary

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Vaccine Efficacy / BNT162 Vaccine Topics: Vaccines / Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2119358

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google